Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
    • Internet & Telecom
  • Toggle search form
  • [Research] Samsung Electro-Mechanics (009150) – SK Securities | Global Tier-1 Multiples · Passive-Substrate Synergy · Embedded & Si-Cap / 2026-05-26 Research
  • [Research] Celltrion (068270) – DS Investment & Securities | 2nd-Gen Biosimilar Penetration · COGS Ratio Stabilization · Global Capacity Expansion / 2026-05-07 Research
  • [Research] Samsung Electronics (005930) – Eugene Investment & Securities | Memory Shortage · Pricing Power · Earnings Upward Revision / 2026-07-08 Research
  • [Research] Samsung Electronics (005930) – Shinhan Securities | Memory Pricing Elasticity · Operating Leverage · Shareholder Return Expectations / 2026-04-06 Research
  • [Research] Alteogen (196170) – Shinhan Securities | Keytruda SC Growth Accelerates · Favorable Contract Terms · Early June PGR Catalysts / 2026-05-11 Research
  • [Research] KEPCO (015760 / KEP) – Daishin Securities | Overseas Nuclear Expansion · Nuclear Utilization Recovery · 2026 Earnings Growth / 2026-02-27 Research
  • [Research] Alteogen (196170) – Shinhan Securities | First UK Patent Ruling Favors Merck · Positive Read-across to Global Disputes · Pipeline Out-Licensing Ahead / 2026-02-23 Research
  • [Research] Samsung SDI (006400) – Mirae Asset Securities | SDC Stake Monetization Pursuit · North America ESS & Europe EV Order Acceleration · Operating Profit Turnaround / 2026-04-29 Research

[Research] Samsung Electro-Mechanics (009150) – iM Securities | MLCC Mix Improvement · FC-BGA Pricing · Earnings Sustainability / 2026-04-06

Posted on 4월 6, 20268월 25, 2026 By ksb220805@gmail.com

Brokerage : iM Securities

Analyst : Eui-young Ko

Investment Rating : Buy (Maintained)

Target Price : KRW 600,000 (Maintained)

Core Momentum : Earnings sustainability and upward forecast revisions driven by server-led MLCC mix improvements, selective order-taking, and the expanding impact of FC-BGA price hikes

📊 1. [Valuation & Key Financial Metrics]

  • Investment Rating & Target Price: Buy maintained; 12-month Target Price maintained at KRW 600,000 (Upside: 31.6%).
  • Valuation Methodology: Applied a 4.1x P/B multiple (a 50% premium over the 2018 peak P/B), representing ~20x 2027F P/E.
  • 1Q26 Earnings Forecast:
    • Operating Profit: KRW 263.1 Billion (-6% vs. 3-month consensus, but +11% above consensus when excluding one-off costs).
    • MLCC capacity utilization surpassed 90% (nearing full utilization), enabling a selective order-taking environment for high-margin products.
  • 2Q26 Earnings Forecast:
    • Projected Operating Profit: KRW 350.5 Billion (+14% upward revision, beating consensus by 7%).
  • Annual Financial Projections (2026E – 2028E):
    • 2026E: Revenue KRW 12.772 Trillion / Operating Profit KRW 1.473 Trillion (+7% revision) / Net Profit KRW 1.163 Trillion
    • 2027E: Revenue KRW 14.449 Trillion / Operating Profit KRW 2.257 Trillion (+4% revision) / Net Profit KRW 1.803 Trillion
    • 2028E: Revenue KRW 15.460 Trillion / Operating Profit KRW 2.780 Trillion / Net Profit KRW 2.235 Trillion
  • Key Financial Multiples (2026E):
    • EPS: KRW 14,983 / BPS: KRW 137,449
    • P/E: 30.4x / P/B: 3.3x
    • ROE: 11.5%
    • EV/EBITDA: 13.5x / Dividend Yield: 0.7%

🚀 2. [Market Opportunities & Business Outlook]

  • Component Division (MLCC):
    • Server-centric product mix improvements are driving rapid profitability expansion even prior to broad-based price increases.
    • Supply-demand balance for commodity MLCC is expected to tighten long term as industry capacity shifts toward surging AI server demand.
    • The analyst establishes a base-case assumption where Murata makes pricing decisions in 2Q26 and raises prices in 3Q26, followed by price hikes from Samsung Electro-Mechanics (every 10% price increase is estimated to boost 2027 operating profit by ~KRW 600 Billion).
  • Package Solutions Division (FC-BGA):
    • Implemented ~10% price increases for select FC-BGA customers in March.
    • Price hike coverage is expected to expand gradually across client bases and product line-ups, accelerating 2Q26 profitability.
    • Second-half earnings expectations are rising sharply as multiple new customer projects transition into mass production.
  • Earnings Sustainability & Multiple Expansion:
    • Transitioning from a typical volatile cyclical model into a sustainable “plateau-type” earnings structure, supported by the data center demand pivot and duopoly structure with Murata.
    • Both MLCC and FC-BGA divisions share synchronized long-term AI-driven visibility.

📝 Editor’s Comment (Perspective)

The analyst views Samsung Electro-Mechanics not merely as a conventional cyclical parts manufacturer exposed to consumer hardware fluctuations, but as a high-value AI hardware beneficiary capable of sustaining high-level “plateau” earnings through structural data center demand and duopolistic market dominance. The underlying perspective places greater strategic significance on selective high-margin order-taking enabled by 90%+ utilization, rapid profitability gains driven purely by product mix upgrades, and expanding pricing pass-through across FC-BGA lines rather than simple shipment volume growth.

To assess whether this investment thesis continues to materialize, key tracking points include the expansion of FC-BGA price hikes across wider customer accounts, quarterly operating margin expansion in the Component division via selective order-taking, and the verification of the analyst’s base-case scenario where Murata executes price increases in 3Q26 followed by Samsung Electro-Mechanics. These developments can be verified through upcoming quarterly earnings releases, official company IR presentations, periodic regulatory filings (quarterly and annual reports), and DART disclosures.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Semiconductors

글 탐색

Previous Post: [Research] Samsung Electro-Mechanics (009150) – Eugene Investment & Securities | AI MLCC · ABF Substrate · Multiple Expansion / 2026-04-03
Next Post: [Research] Samsung Electro-Mechanics (009150) – Daishin Securities | FC-BGA · MLCC · Price Increase / 2026-04-06

Related Posts

  • [Research] LIG D&A (079550) – Hana Securities | 1Q26 Earnings Beat · Backlog Re-rating · High-margin Follow-on Services / 2026-05-08 Research
  • [Research] ABL Bio (298380) – DS Investment & Securities | Sanofi Strategy · Grabody B Validity · Muscle Shuttle Expansion / 2026-02-02 Research
  • [Research] SK hynix (000660 / SKHY) – SK Securities | AI Memory · NAND Tiering · Earnings Re-rating / 2026-02-24 Research
  • [Research] Samsung SDI (006400) – SK Securities | Prominent Base Effects · Conservative CapEx Management · Compelling Valuation / 2026-02-03 Research
  • [Research] Samsung Electro-Mechanics (009150) – Hana Securities | MLCC & FCBGA Shortage · LTA Expansion · 2027 Peer Multiple / 2026-05-04 Research
  • [Research] Samsung SDI (006400) – Kyobo Securities | Gradual Loss Narrowing · Solid-State Battery Development Pipeline · Robotics Partnerships / 2026-02-03 Research
  • [Research] Hanwha Ocean (042660) – DS Investment & Securities | Low-Price Mix Reduction · Merchant Margin Step-Up · MASGA & Defense Pipeline / 2026-04-28 Research
  • [Research] Samsung SDI (006400) – Kyobo Securities | Gradual Loss Narrowing · Solid-State Battery Development Pipeline · Robotics Partnerships / 2026-02-03 Research
  • [Research] Samsung Biologics (207940) – Daishin Securities | Peptide Market Entry · Global Footprint Expansion · Modality Diversification / 2026-07-21 Research
  • [Research] LigaChem Biosciences (141080) – Kyobo Securities | Pipeline Clinical Progress · IND Filings · Tech Transfer / 2026-04-01 Research
  • [Research] Samsung Electro-Mechanics (009150) – Daishin Securities | FC-BGA Investment · MLCC Supply Shortage · Valuation Re-rating / 2026-04-22 Research
  • [Research] LIG D&A (079550) – Yuanta Securities | 4Q25 Review · Conservative 2026E Guidance · Long-term Structural Growth / 2026-02-19 Research
  • [Research] Samsung Electronics (005930) – Daishin Securities | Commodity Memory ASP Growth · Full-Year Profit Over KRW 200T · Cash Asset Expansion / 2026-02-23 Research
  • [Research] LIG D&A (079550) – Hana Securities | Complementing Patriot · Cheongung-II Cost Competitiveness · KRW 26.2T Backlog / 2026-03-03 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme